GlassScriptPhysician profile
George Steven Selas
NPI 1518125376
$10,593.69
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,002 · 2020: $300 · 2021: $1,756 · 2022: $1,520 · 2023: $5,891 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,890 · Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,890.10 |
| Food and Beverage | $1,125.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,092.44 | 2021-2023 | Pipeline, Solitaire X |
| Stryker Corporation | $1,534.39 | 2019-2023 | Evolve, Surpass Evolve |
| Microvention, INC. | $1,304.17 | 2019-2023 | Web Aneurysm Embolization System, Stent |
| Rapid Medical LTD | $1,162.16 | 2022-2023 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Medical Device Business Services, INC. | $1,035.69 | 2021-2022 | |
| Penumbra, INC. | $711.57 | 2019-2023 | Benchmark |
| Balt USA, LLC | $199.46 | 2021 | |
| Incyte Corporation | $125.00 | 2024 | Monjuvi |
| Astrazeneca Pharmaceuticals LP | $121.81 | 2021 | |
| Medtronic USA, INC. | $119.70 | 2019-2020 | |
| Epizyme, INC. | $115.12 | 2021 | |
| Depuy Synthes Sales INC. | $40.09 | 2021 | |
| Ucb, INC. | $20.89 | 2022 | |
| Phenox INC. | $11.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Selas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.